Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 14
Weight After Stopping Rybelsus
Weight regain can follow semaglutide withdrawal, but direct evidence after stopping oral Rybelsus remains limited and needs careful context.
CX11 Data Behind Corxel's SPAC Deal
Corxel's SPAC plan rests partly on a company-reported CX11 Phase 2 result. The registry confirms the study design, but not the result.
China semaglutide equivalence trial
A 481-person Chinese trial found equivalent 32-week HbA1c lowering for two study semaglutide injections in people using metformin.
GLP-1 drugs and arrhythmia meta-analysis
A 2026 network meta-analysis linked subcutaneous semaglutide with fewer reported atrial-fibrillation events, but it cannot establish an AF treatment.
GLP-1 Weight Loss and Endocrine Therapy
A 269-patient retrospective cohort reports GLP-1-associated weight change during adjuvant endocrine therapy for breast cancer.
Rapid Weight Gain Before Semaglutide
Rapid unintentional weight gain needs assessment before a semaglutide decision because medicines, medical conditions, and fluid can contribute.
Retatrutide side effects in trials
Retatrutide trials most often report gastrointestinal events and a dose-related heart-rate increase, but there is no approved safety label yet.
Semaglutide 1 mg Versus 2 mg
Semaglutide 2 mg produced modest extra glucose lowering versus 1 mg in one diabetes trial, but pen strengths and indications still govern use.
Semaglutide and Concomitant Medicines
A Danish register study found shifts in several prescribing categories after semaglutide initiation, but it cannot establish causation.
Does Semaglutide Change Food Enjoyment?
Semaglutide studies find lower energy intake and cravings, but they do not identify a universal list of foods or drinks people will still enjoy.
How to Read Semaglutide Progress Photos
A semaglutide before-and-after image can describe one person's experience, but it cannot establish cause, safety, product identity, or a result for others.
How CJC-1295 Works
CJC-1295 signals the pituitary to release growth hormone, while its studied albumin-binding design extends exposure for days.